Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C23H30N6O6 |
Molecular Weight | 486.5209 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C=NC3=C2N=C(N=C3N)C#CC[C@H]4CC[C@@H](CC4)C(=O)OC
InChI
InChIKey=FLEVIENZILQUKB-XTWQNQIISA-N
InChI=1S/C23H30N6O6/c1-3-25-21(32)18-16(30)17(31)22(35-18)29-11-26-15-19(24)27-14(28-20(15)29)6-4-5-12-7-9-13(10-8-12)23(33)34-2/h11-13,16-18,22,30-31H,3,5,7-10H2,1-2H3,(H,25,32)(H2,24,27,28)/t12-,13-,16-,17+,18-,22+/m0/s1
Apadenoson (BMS-068645) is a selective adenosine 2A agonist that contains a methyl ester group which undergoes esterase hydrolysis to its acid metabolite. Apadenoson had been in phase III clinical trials by Forest (now a part of Allergan) for the treatment of coronary artery disease. However, this study has been terminated.
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Selective A(2A) adenosine receptor activation reduces skin pressure ulcer formation and inflammation. | 2001 Jul |
|
Adenosine A2A receptor activation decreases reperfusion injury associated with high-flow reperfusion. | 2002 Nov |
|
Influence of propranolol, enalaprilat, verapamil, and caffeine on adenosine A(2A)-receptor-mediated coronary vasodilation. | 2002 Nov 6 |
|
Adenosine receptors as therapeutic targets. | 2006 Mar |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT01313572
Coronary artery disease: Apadenoson single bolus IV injection 100 or 150 ug
Route of Administration:
Intravenous
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29707
Created by
admin on Fri Dec 15 16:16:16 GMT 2023 , Edited by admin on Fri Dec 15 16:16:16 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
8711
Created by
admin on Fri Dec 15 16:16:16 GMT 2023 , Edited by admin on Fri Dec 15 16:16:16 GMT 2023
|
PRIMARY | |||
|
CHEMBL1950649
Created by
admin on Fri Dec 15 16:16:16 GMT 2023 , Edited by admin on Fri Dec 15 16:16:16 GMT 2023
|
PRIMARY | |||
|
C74246
Created by
admin on Fri Dec 15 16:16:16 GMT 2023 , Edited by admin on Fri Dec 15 16:16:16 GMT 2023
|
PRIMARY | |||
|
SUB32278
Created by
admin on Fri Dec 15 16:16:16 GMT 2023 , Edited by admin on Fri Dec 15 16:16:16 GMT 2023
|
PRIMARY | |||
|
250386-15-3
Created by
admin on Fri Dec 15 16:16:16 GMT 2023 , Edited by admin on Fri Dec 15 16:16:16 GMT 2023
|
PRIMARY | |||
|
BTS1Y6777M
Created by
admin on Fri Dec 15 16:16:16 GMT 2023 , Edited by admin on Fri Dec 15 16:16:16 GMT 2023
|
PRIMARY | |||
|
100000124362
Created by
admin on Fri Dec 15 16:16:16 GMT 2023 , Edited by admin on Fri Dec 15 16:16:16 GMT 2023
|
PRIMARY | |||
|
RR-04
Created by
admin on Fri Dec 15 16:16:16 GMT 2023 , Edited by admin on Fri Dec 15 16:16:16 GMT 2023
|
PRIMARY | |||
|
DB05009
Created by
admin on Fri Dec 15 16:16:16 GMT 2023 , Edited by admin on Fri Dec 15 16:16:16 GMT 2023
|
PRIMARY |
ACTIVE MOIETY